
Azacitidine Program in Pharmaceutical Benefits Scheme (PBS) 012-18051104

-   Background
-   Process
-   Resources

[Expand/Collapse all sections]Expand all

For information on how to process a PBS Authority see Processing Written
Authority Required Listings. Contact a Program Support Officer (PSO) if
unsure how to action an application.

Azacitidine quick reference

Note: this page has been decommissioned and is for information only. See
AML, CMML and the MDS programs for current information.

+-----------+-----------+-----------+-----------+-----------+-----------+
| Res       | Authority | PA        | P         | P         | P         |
| trictions | level and | a         | rocessing | rescriber | rescriber |
|           | section   | ssessment | system    | type      | s         |
|           |           |           |           |           | elf-serve |
+-----------+-----------+-----------+-----------+-----------+-----------+
| Initial   | Written   | No        | OPA       | Not       | Yes       |
|           |           |           |           | specified |           |
| CMML      | E         |           |           |           |           |
|           | lectronic |           |           |           |           |
| PB079     |           |           |           |           |           |
| form      | S100      |           |           |           |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| Initial   | Telephone | No        | OPA       | Not       | Yes       |
|           |           |           |           | specified |           |
| AML       | E         |           |           |           |           |
|           | lectronic |           |           |           |           |
| MDS       |           |           |           |           |           |
|           | S100      |           |           |           |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| C         | Telephone | No        | OPA       | Not       | Yes       |
| ontinuing |           |           |           | specified |           |
|           | E         |           |           |           |           |
| CMML      | lectronic |           |           |           |           |
|           |           |           |           |           |           |
| MDS       | S100      |           |           |           |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| C         | St        | No        | OPA       | Not       | N/A       |
| ontinuing | reamlined |           |           | specified |           |
|           |           |           |           |           |           |
| AML       | S100      |           |           |           |           |
|           |           |           |           |           |           |
|           | (         |           |           |           |           |
|           | Telephone |           |           |           |           |
|           | for       |           |           |           |           |
|           | increased |           |           |           |           |
|           | q         |           |           |           |           |
|           | uantities |           |           |           |           |
|           | of        |           |           |           |           |
|           | aza       |           |           |           |           |
|           | citidine) |           |           |           |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| Az        | Telephone | No        | OPA       | Not       | Yes       |
| acitidine |           |           |           | specified |           |
| in        | E         |           |           |           |           |
| co        | lectronic |           |           |           |           |
| mbination |           |           |           |           |           |
| with      | S100:     |           |           |           |           |
| v         |           |           |           |           |           |
| enetoclax | az        |           |           |           |           |
| (dual     | acitidine |           |           |           |           |
| therapy)  |           |           |           |           |           |
|           | S85:      |           |           |           |           |
| AML       |           |           |           |           |           |
|           | v         |           |           |           |           |
|           | enetoclax |           |           |           |           |
+-----------+-----------+-----------+-----------+-----------+-----------+

                                   

-   Services Australia ABN 90 794 605 008 
